New Perspectives in Clostridium difficile Disease Pathogenesis

作者: Tanya M. Monaghan

DOI: 10.1016/J.IDC.2014.11.007

关键词:

摘要: Clostridium difficile is associated with a spectrum of clinical manifestations ranging from asymptomatic carriage to severe life-threatening pseudomembranous colitis. Current perspectives indicate that C pathogenesis multifactorial disease process dictated by pathogenic toxin production, gut microbial dysbiosis, and altered host inflammatory responses. This article summarizes recent findings underpinning the cellular molecular mechanisms regulating bacterial virulence sheds new light on critical roles immune response, intestinal microbiota, metabolome in mediating pathogenesis.

参考文章(96)
B. Aronsson, M. Granström, R. Möllby, C. E. Nord, Serum antibody response to clostridium difficile toxins in patients with clostridium difficile diarrhoea Infection. ,vol. 13, pp. 97- 101 ,(1985) , 10.1007/BF01642866
L.J. Wheeldon, T. Worthington, P.A. Lambert, Histidine acts as a co-germinant with glycine and taurocholate for Clostridium difficile spores Journal of Applied Microbiology. ,vol. 110, pp. 987- 994 ,(2011) , 10.1111/J.1365-2672.2011.04953.X
Ana Antunes, Isabelle Martin-Verstraete, Bruno Dupuy, CcpA-mediated repression of Clostridium difficile toxin gene expression. Molecular Microbiology. ,vol. 79, pp. 882- 899 ,(2011) , 10.1111/J.1365-2958.2010.07495.X
KAI SOO TAN, BOON YU WEE, KEANG PENG SONG, Evidence for holin function of tcdE gene in the pathogenicity of Clostridium difficile. Journal of Medical Microbiology. ,vol. 50, pp. 613- 619 ,(2001) , 10.1099/0022-1317-50-7-613
P. Papatheodorou, J. E. Carette, G. W. Bell, C. Schwan, G. Guttenberg, T. R. Brummelkamp, K. Aktories, Lipolysis-stimulated lipoprotein receptor (LSR) is the host receptor for the binary toxin Clostridium difficile transferase (CDT) Proceedings of the National Academy of Sciences of the United States of America. ,vol. 108, pp. 16422- 16427 ,(2011) , 10.1073/PNAS.1109772108
Maja Rupnik, Mark H. Wilcox, Dale N. Gerding, Clostridium difficile infection: new developments in epidemiology and pathogenesis Nature Reviews Microbiology. ,vol. 7, pp. 526- 536 ,(2009) , 10.1038/NRMICRO2164
Sean S. Dineen, Anuradha C. Villapakkam, Jared T. Nordman, Abraham L. Sonenshein, Repression of Clostridium difficile toxin gene expression by CodY Molecular Microbiology. ,vol. 66, pp. 206- 219 ,(2007) , 10.1111/J.1365-2958.2007.05906.X
B. Elliott, B. J. Chang, C. L. Golledge, T. V. Riley, Clostridium difficile-associated diarrhoea Internal Medicine Journal. ,vol. 37, pp. 561- 568 ,(2007) , 10.1111/J.1445-5994.2007.01403.X
Rosanna Leuzzi, Roberto Adamo, Maria Scarselli, Vaccines against Clostridium difficile Human Vaccines & Immunotherapeutics. ,vol. 10, pp. 1466- 1477 ,(2014) , 10.4161/HV.28428
Casey M. Theriot, Mark J. Koenigsknecht, Paul E. Carlson, Gabrielle E. Hatton, Adam M. Nelson, Bo Li, Gary B. Huffnagle, Jun Z. Li, Vincent B. Young, Antibiotic-induced shifts in the mouse gut microbiome and metabolome increase susceptibility to Clostridium difficile infection Nature Communications. ,vol. 5, pp. 3114- 3114 ,(2014) , 10.1038/NCOMMS4114